Further validation using qRT–PCR in 100 paired thyroid cancer and adjacent normal tissues revealed consistent upregulation of ACSL5 and NCF2 in tumour tissues and downregulation of HSD17B11, CCL5, and ACTB. This evidence concerns the gene HSD17B11 and thyroid gland carcinoma.